Thimerosal, a controversial mercury-based preservative, faced a consequential vote at the Advisory Committee on Immunization Practices (ACIP) meeting. The panel advises the Centers for Disease Control and Prevention (CDC) on the vaccine schedule and held its first meeting since Health and Human Services (HHS) Secretary Robert F.